Blocking FcαR1 (CD89)/IgA interaction using CD89 specific antibodies is a potential therapeutic target to resolve tissue damage in chronic inflammation and autoimmunity

M.A.M. van Delft - Soffers; E. Aleyd; M. van Egmond; R van der Mast; Louis Boon; Peter J Simons

Blocking FcαR1 (CD89)/IgA interaction using CD89 specific antibodies is a potential therapeutic target to resolve tissue damage in chronic inflammation and autoimmunity

M.A.M. van Delft - Soffers, E. Aleyd, M. van Egmond, R van der Mast, Louis Boon, Peter J Simons

Molecular cell biology and Immunology (VUmc)
Surgery (VUmc)
CCA - Cancer biology and immunology (VUmc)
AII - Inflammatory diseases (VUmc)
AII - Cancer immunology (VUmc)

Research output: Contribution to conference › Abstract › Academic

Original language	English
Publication status	Published - 2022

Cite this

@conference{f4ca20f0d126452e95386f824c1c3641,

title = "Blocking FcαR1 (CD89)/IgA interaction using CD89 specific antibodies is a potential therapeutic target to resolve tissue damage in chronic inflammation and autoimmunity",

author = "{van Delft - Soffers}, M.A.M. and E. Aleyd and {van Egmond}, M. and {van der Mast}, R and Louis Boon and Simons, {Peter J}",

year = "2022",

language = "English",

}